| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
34 |
| Employees |
420 |
| Revenues (TTM) (Millions $) |
104 |
| Net Income (TTM) (Millions $) |
-56 |
| Cash Flow (TTM) (Millions $) |
10 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Intersect Ent Inc is a medical technology company that focuses on developing innovative solutions for the treatment of various ear, nose, and throat (ENT) conditions. The company was founded in 2003 and is headquartered in Menlo Park, California. Intersect ENT operates in the medical device industry and has a range of products that are designed to treat conditions such as chronic sinusitis, nasal polyps, and other ENT disorders.
One of the key products that has made Intersect ENT a leader in the market is the PROPEL sinus stent. The stent is a small, biodegradable device that is placed in the sinus cavity after a surgical procedure to open up the sinuses. The PROPEL stent provides structural support and localized drug delivery to reduce inflammation and minimize scar tissue formation. The stent is gradually reabsorbed by the body, which eliminates the need for a second surgical procedure to remove it.
Intersect ENT also has a product line for treating nasal obstruction, which includes the SINUVA sinus implant. The implant is a small, removable device that is placed in the sinus cavity to provide structural support and open up the airway. The implant is made from a bioabsorbable material and is designed to gradually dissolve over time, leaving nothing behind.
The company's products are sold in the United States and internationally, and the company has partnerships with leading medical device distributors and healthcare providers. Intersect ENT has invested heavily in research and development, and it has a portfolio of patents and intellectual property that supports its continued growth and innovation.
Intersect ENT has won numerous awards for its innovative products and its commitment to improving patient outcomes. The company is dedicated to developing new technologies and treatments that can improve the quality of life for people suffering from ENT conditions. With its strong financial position, innovative products, and talented team, Intersect ENT is poised for continued growth and success in the medical device industry.
Company Address: 1555 Adams Drive Menlo Park 94025 CA
Company Phone Number: 641-2100 Stock Exchange / Ticker: NASDAQ XENT
|
%